Search
for
Sort by
Research 271–300 of 1000+
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Cutaneous side-effects of EGFR inhibitors and their management.
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Mimosine Dipeptide Enantiomsers: Improved Inhibitors against Melanogenesis and Cyclooxygenase
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Pyruvate Kinase M2 Role in Cardiovascular Repair